10% Owner Sells $267K of Bio Green Med (BGMS) Stock
Bio Green Med Solution, Inc.
Subscribe to track BGMS
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
10% Owner Sells $267K of Bio Green Med (BGMS) Stock
Company: Bio Green Med Solution, Inc. (BGMS) Form: 4 | Filed: 2025-10-10 Significance: High
Insider: Kua Khai Loon Title: null | Relationship: Ten Percent Owner
Transaction (Aggregated): • Type: Sale • Shares: 47,251 • Price: ~$5.65 (VWAP) • Value: $266,814 • Owned After: 338,160
Key Insight: A major 10% owner liquidated over 12% of their direct holdings across two separate sales on Sept 12 and Sept 16, signaling potential profit-taking or a bearish outlook.
Market Context: This significant sale by a key stakeholder could be viewed negatively by the market and may lead to increased scrutiny of the company's near-term prospects.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Bio Green Med Solution, Inc. (BGMS)
Executive Summary
- Trading Significance: High
- Key Takeaway: A 10% owner, Kua Khai Loon, sold 47,251 shares for approximately $267k, reducing their direct holdings by over 12%. This is a notable disposition from a major stakeholder.
- Market Impact: This series of sales is a bearish signal. The market may interpret this as an insider believing the stock is fully valued or anticipating future headwinds, potentially leading to negative price pressure.
Company Information
| Field | Value |
|---|---|
| Company | Bio Green Med Solution, Inc. |
| Ticker Symbol | BGMS |
| CIK | 0001130166 |
| Industry | Pharmaceutical Preparations |
Insider Information
| Field | Value |
|---|---|
| Name | Kua Khai Loon |
| CIK | 0002081556 |
| Title/Position | null |
| Relationship | Ten Percent Owner |
Transaction Details
Note: This filing reported two separate sale transactions. The figures below are aggregated for a comprehensive view.
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-09-12 to 2025-09-16 |
| Transaction Code | S (Sale) |
| Security Type | Common Stock |
| Shares Involved | 47,251 |
| Price Per Share | ~$5.65 (Volume Weighted Average) |
| Total Value | $266,814.22 |
| Shares Owned After | 338,160 |
| Ownership Type | Direct |
Market Impact Analysis
Stock Impact Prediction
- Direction: Negative
- Reasoning: Sales from 10% owners are closely watched indicators. A disposition of this size, representing over 12% of the insider's stake, suggests a reduced conviction in the stock's short-to-medium term appreciation potential. Other investors may follow this signal, leading to downward pressure on the stock price.
Volume & Sentiment
- Expected Volume Impact: An increase in trading volume is possible as the market digests this information and other shareholders react.
- Sentiment Indicator: Bearish. Insider selling, especially from a non-officer major shareholder, is typically viewed as a negative indicator.
Investment Insights
Positive Market Indicators
- The insider still maintains a very large position of 338,160 shares, indicating continued significant alignment with shareholder interests.
Risk Factors
- The seller is a 10% owner, making their actions highly significant.
- The sale represents a material reduction (over 12%) of the insider's holdings.
- The sales occurred over two separate days, suggesting a deliberate effort to reduce exposure rather than a single, unplanned trade.
Key Takeaways
- Significant Insider Sale: A major stakeholder has cashed out a portion of their investment.
- Bearish Signal: The action implies the insider may not see compelling value at current price levels.
- Substantial Remaining Stake: Despite the sale, the insider remains a major shareholder, which mitigates the negative signal to some extent.
Contextual Analysis
Timing Significance
The sales took place in mid-September, with the filing occurring nearly a month later. The delay is within legal limits but means the market is reacting to dated information. The different prices ($6.224 and $5.132) show the sales occurred in a volatile period for the stock.
Transaction Context
No 10b5-1 trading plan was indicated in the filing. This suggests the sales were discretionary decisions made by the insider at that time.
Company Context
This analysis is based solely on the filing. Further research into Bio Green Med Solution's recent news, financial performance, and sector trends is necessary for a complete picture.
Risk Assessment
Risk Level: High
Risk Factors
- Confidence Erosion: A significant sale from a major owner can erode confidence among retail and institutional investors.
- Valuation Concerns: The sale may signal that the insider perceives the stock as being fairly or over-valued.
- Lack of Pre-Planned Sale: The absence of a 10b5-1 plan makes the sale appear more opportunistic and tied to the insider's current market view.
Market Considerations
- The market's reaction will depend on the stock's recent performance and the broader market sentiment.
- Investors should monitor for further insider selling from this individual or others within the company.
- The sale provides a data point that should be weighed against the company's fundamental strengths and weaknesses.
IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.
Analysis generated on 2025-10-10 | Data source: SEC EDGAR
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.